High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 07 2019
Historique:
received: 13 12 2018
accepted: 10 06 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 18 12 2019
Statut: epublish

Résumé

High-throughput single-cell RNA sequencing is a powerful technique but only generates short reads from one end of a cDNA template, limiting the reconstruction of highly diverse sequences such as antigen receptors. To overcome this limitation, we combined targeted capture and long-read sequencing of T-cell-receptor (TCR) and B-cell-receptor (BCR) mRNA transcripts with short-read transcriptome profiling of barcoded single-cell libraries generated by droplet-based partitioning. We show that Repertoire and Gene Expression by Sequencing (RAGE-Seq) can generate accurate full-length antigen receptor sequences at nucleotide resolution, infer B-cell clonal evolution and identify alternatively spliced BCR transcripts. We apply RAGE-Seq to 7138 cells sampled from the primary tumor and draining lymph node of a breast cancer patient to track transcriptome profiles of expanded lymphocyte clones across tissues. Our results demonstrate that RAGE-Seq is a powerful method for tracking the clonal evolution from large numbers of lymphocytes applicable to the study of immunity, autoimmunity and cancer.

Identifiants

pubmed: 31311926
doi: 10.1038/s41467-019-11049-4
pii: 10.1038/s41467-019-11049-4
pmc: PMC6635368
doi:

Substances chimiques

Receptors, Antigen, B-Cell 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3120

Références

Mol Cell. 2017 Feb 16;65(4):631-643.e4
pubmed: 28212749
Sci Transl Med. 2014 May 28;6(238):238ra70
pubmed: 24871131
PLoS Comput Biol. 2018 Nov 20;14(11):e1006583
pubmed: 30458005
Bioinformatics. 2018 Aug 15;34(16):2846-2847
pubmed: 29659703
Cancer Immunol Immunother. 2012 Jul;61(7):1019-31
pubmed: 22146893
Nat Rev Clin Oncol. 2016 Apr;13(4):228-41
pubmed: 26667975
Genome Med. 2018 Mar 20;10(1):20
pubmed: 29558968
Trends Cancer. 2015 Dec 1;1(4):217-230
pubmed: 26726318
Nat Protoc. 2014 Jan;9(1):171-81
pubmed: 24385147
Nucleic Acids Res. 2017 Sep 19;45(16):e148
pubmed: 28934479
J Exp Med. 1984 Sep 1;160(3):877-92
pubmed: 6206193
Nucleic Acids Res. 2015 Jan;43(Database issue):D413-22
pubmed: 25378316
Science. 2015 Feb 6;347(6222):1258367
pubmed: 25657253
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
PLoS Biol. 2003 Oct;1(1):E16
pubmed: 14551913
Cell. 1980 Jun;20(2):293-301
pubmed: 6771018
Nat Biotechnol. 2017 Oct;35(10):936-939
pubmed: 28854175
Science. 2017 Oct 6;358(6359):58-63
pubmed: 28983043
Immunol Cell Biol. 2016 Jul;94(6):604-11
pubmed: 26860370
Immunity. 2017 Feb 21;46(2):287-300
pubmed: 28214226
Nat Methods. 2016 Apr;13(4):329-332
pubmed: 26950746
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Sci Rep. 2017 Mar 14;7:44447
pubmed: 28290550
J Exp Med. 2013 Oct 21;210(11):2305-20
pubmed: 24101382
Immunity. 1998 Dec;9(6):859-69
pubmed: 9881976
Science. 2018 Apr 13;360(6385):176-182
pubmed: 29545511
Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):
pubmed: 26150657
Nat Biotechnol. 2018 Oct 15;:
pubmed: 30320766
Nat Commun. 2013;4:2680
pubmed: 24157944
Nat Methods. 2013 Nov;10(11):1096-8
pubmed: 24056875
J Immunol. 1984 Mar;132(3):1561-5
pubmed: 6420468
Sci Rep. 2017 Oct 6;7(1):12781
pubmed: 28986563
Genome Res. 2017 May;27(5):737-746
pubmed: 28100585
Trends Immunol. 2014 Oct 8;35(12):581-590
pubmed: 25306219
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Nat Rev Immunol. 2004 Jul;4(7):541-52
pubmed: 15229473
Science. 2017 Aug 18;357(6352):661-667
pubmed: 28818938
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Proc Natl Acad Sci U S A. 1985 May;82(10):3430-4
pubmed: 3873654
J Immunol. 2006 Feb 1;176(3):1543-52
pubmed: 16424183
Cell. 2018 May 17;173(5):1307
pubmed: 29775597
Nat Methods. 2019 Jan;16(1):59-62
pubmed: 30559431
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Nucleic Acids Res. 2015 Dec 2;43(21):e143
pubmed: 26187991
Nat Methods. 2015 Aug;12(8):733-5
pubmed: 26076426
Cancer. 1981 Sep 15;48(6):1368-76
pubmed: 6268284
Nat Immunol. 2013 Jul;14(7):706-13
pubmed: 23727893
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Blood. 1996 Nov 1;88(9):3562-8
pubmed: 8896424
Sci Transl Med. 2015 Aug 26;7(302):302ra135
pubmed: 26311730
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Commun. 2017 Jul 19;8:16027
pubmed: 28722025
Nat Rev Immunol. 2018 Jan;18(1):35-45
pubmed: 28787399
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Nat Methods. 2017 Apr;14(4):395-398
pubmed: 28192419
Cell. 1981 May;24(2):353-65
pubmed: 6786756
Cell. 2015 May 21;161(5):1187-1201
pubmed: 26000487
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
J Transl Med. 2018 Jan 10;16(1):3
pubmed: 29316940
Cell. 2018 Jan 25;172(3):549-563.e16
pubmed: 29275860
Cell. 2002 Apr;109 Suppl:S45-55
pubmed: 11983152
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923
Nat Methods. 2014 Jun;11(6):653-5
pubmed: 24793455

Auteurs

Mandeep Singh (M)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Ghamdan Al-Eryani (G)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Shaun Carswell (S)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

James M Ferguson (JM)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.

James Blackburn (J)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Kirston Barton (K)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Daniel Roden (D)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Fabio Luciani (F)

St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Kirby Institute for Infection and Immunity, School of Medical Sciences, UNSW, Sydney, NSW, 2052, Australia.

Tri Giang Phan (T)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Simon Junankar (S)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Katherine Jackson (K)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.

Christopher C Goodnow (CC)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. c.goodnow@garvan.org.au.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia. c.goodnow@garvan.org.au.

Martin A Smith (MA)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. martinalexandersmith@gmail.com.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia. martinalexandersmith@gmail.com.

Alexander Swarbrick (A)

Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. a.swarbrick@garvan.org.au.
St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia. a.swarbrick@garvan.org.au.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH